Muller WJ - Search Results

1

ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer.

Deblois G, Smith HW, Tam IS, Gravel SP, Caron M, Savage P, Labbé DP, Bégin LR, Tremblay ML, Park M, Bourque G, St-Pierre J, Muller WJ, Giguère V. Deblois G, et al. Among authors: muller wj. Nat Commun. 2016 Jul 12;7:12156. doi: 10.1038/ncomms12156. Nat Commun. 2016. PMID: 27402251 Free PMC article.

2

Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.

Khoury H, Dankort DL, Sadekova S, Naujokas MA, Muller WJ, Park M. Khoury H, et al. Among authors: muller wj. Oncogene. 2001 Feb 15;20(7):788-99. doi: 10.1038/sj.onc.1204166. Oncogene. 2001. PMID: 11314013

3

HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion.

Khoury H, Naujokas MA, Zuo D, Sangwan V, Frigault MM, Petkiewicz S, Dankort DL, Muller WJ, Park M. Khoury H, et al. Among authors: muller wj. Mol Biol Cell. 2005 Feb;16(2):550-61. doi: 10.1091/mbc.e04-07-0567. Epub 2004 Nov 17. Mol Biol Cell. 2005. PMID: 15548598 Free PMC article.

4

The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation.

Kim H, Chan R, Dankort DL, Zuo D, Najoukas M, Park M, Muller WJ. Kim H, et al. Among authors: muller wj. Oncogene. 2005 Nov 17;24(51):7599-607. doi: 10.1038/sj.onc.1208898. Oncogene. 2005. PMID: 16170374

5

Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.

Julien SG, Dubé N, Read M, Penney J, Paquet M, Han Y, Kennedy BP, Muller WJ, Tremblay ML. Julien SG, et al. Among authors: muller wj. Nat Genet. 2007 Mar;39(3):338-46. doi: 10.1038/ng1963. Epub 2007 Jan 28. Nat Genet. 2007. PMID: 17259984

6

Insights from transgenic mouse models of ERBB2-induced breast cancer.

Ursini-Siegel J, Schade B, Cardiff RD, Muller WJ. Ursini-Siegel J, et al. Among authors: muller wj. Nat Rev Cancer. 2007 May;7(5):389-97. doi: 10.1038/nrc2127. Epub 2007 Apr 19. Nat Rev Cancer. 2007. PMID: 17446858 Review.

7

Integrins in mammary-stem-cell biology and breast-cancer progression--a role in cancer stem cells?

Pontier SM, Muller WJ. Pontier SM, et al. Among authors: muller wj. J Cell Sci. 2009 Jan 15;122(Pt 2):207-14. doi: 10.1242/jcs.040394. J Cell Sci. 2009. PMID: 19118213 Free PMC article. Review.

8

Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer.

Pontier SM, Huck L, White DE, Rayment J, Sanguin-Gendreau V, Hennessy B, Zuo D, St-Arnaud R, Mills GB, Dedhar S, Marshall CJ, Muller WJ. Pontier SM, et al. Among authors: muller wj. Oncogene. 2010 Jun 10;29(23):3374-85. doi: 10.1038/onc.2010.86. Epub 2010 Mar 22. Oncogene. 2010. PMID: 20305688

9

Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.

Hardy S, Wong NN, Muller WJ, Park M, Tremblay ML. Hardy S, et al. Among authors: muller wj. Cancer Res. 2010 Nov 1;70(21):8959-67. doi: 10.1158/0008-5472.CAN-10-2041. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841483

10

Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Ursini-Siegel J, Cory S, Zuo D, Hardy WR, Rexhepaj E, Lam S, Schade B, Jirstrom K, Bjur E, Piccirillo CA, Denardo D, Coussens LM, Brennan DJ, Gallagher WM, Park M, Pawson T, Hallett M, Muller WJ. Ursini-Siegel J, et al. Among authors: muller wj. Cancer Res. 2010 Oct 15;70(20):7776-87. doi: 10.1158/0008-5472.CAN-10-2229. Epub 2010 Oct 5. Cancer Res. 2010. PMID: 20924104 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters